Silver Diamine Fluoride is one of 43 small molecule programs targeting Primary Teeth. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
73 competitors in Effectiveness
Kesimpta
Mounjaro
Actos
Nicotine Free Cigarettes
Botulinum Toxin a
Droxia
Haldol
Temodar
Pneumococcal Conjugate Vaccine
Silver Diamine Fluoride
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details